The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial

BACKGROUND: The OPTION trial results showed that premenopausal women with early stage breast cancer (EBC) receiving chemotherapy benefited from ovarian function protection with goserelin. The impact of treatments on patient reported Quality of Life (QoL) were also examined. PATIENTS AND METHODS: 227...

Descripción completa

Detalles Bibliográficos
Autores principales: R, Leonard, A, Yellowlees, J, Mansi, L, Fallowfield, V, Jenkins
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303950/
https://www.ncbi.nlm.nih.gov/pubmed/32505861
http://dx.doi.org/10.1016/j.breast.2020.05.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303950/
https://www.ncbi.nlm.nih.gov/pubmed/32505861
http://dx.doi.org/10.1016/j.breast.2020.05.009

Ejemplares similares